Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
63
Views
15
CrossRef citations to date
0
Altmetric
Original Research

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

Zhi-Wei Lu1 The Fourth Clinical School of Nanjing Medical University, Nanjing, Jiangsu, China;2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Ming-Yu Du2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Lu-Xi Qian1 The Fourth Clinical School of Nanjing Medical University, Nanjing, Jiangsu, China;2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Nan Zhang2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Jia-Jia Gu2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Kai Ding3 Department of Radiation Oncology, Suqian First Hospital, Suqian, Jiangsu, China
,
Jing Wu2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Hong-Ming Zhu2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China
,
Xia He1 The Fourth Clinical School of Nanjing Medical University, Nanjing, Jiangsu, China;2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, ChinaCorrespondence[email protected] [email protected]
&
Li Yin1 The Fourth Clinical School of Nanjing Medical University, Nanjing, Jiangsu, China;2 Department of Radiation Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, ChinaCorrespondence[email protected] [email protected]
 show all
Pages 1733-1741 | Published online: 27 Mar 2018

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lucas Alvizi, Luciano Abreu Brito, Gerson Shigeru Kobayashi, Bárbara Bischain, Camila Bassi Fernandes da Silva, Sofia Ligia Guimaraes Ramos, Jaqueline Wang & Maria Rita Passos-Bueno. (2022) mir152 hypomethylation as a mechanism for non-syndromic cleft lip and palate. Epigenetics 17:13, pages 2278-2295.
Read now
Ji-Fu Zheng, Ning-Hong Guo, Fu-Ming Zi & Jing Cheng. (2020) Long Noncoding RNA H19 Promotes Tumorigenesis of Multiple Myeloma by Activating BRD4 Signaling by Targeting MicroRNA 152-3p. Molecular and Cellular Biology 40:3.
Read now

Articles from other publishers (13)

Bo Bin Lee, Dongho Kim, Yujin Kim, Joungho Han, Young Mog Shim & Duk-Hwan Kim. (2023) Metformin regulates expression of DNA methyltransferases through the miR-148/-152 family in non-small lung cancer cells. Clinical Epigenetics 15:1.
Crossref
Zhuojun Deng, Jiaqi Yao, Na Xiao, Yu Han, Xuan Wu, Caizhe Ci, Ke Chen & Xiaoyong Geng. (2022) DNA methyltransferase 1 (DNMT1) suppresses mitophagy and aggravates heart failure via the microRNA-152-3p/ETS1/RhoH axis. Laboratory Investigation 102:8, pages 782-793.
Crossref
Bo Tu, Ling Ye, Qingsong Cao, Sisi Gong, Miaohua Jiang & Hui Li. (2022) Identification of a five-miRNA signature as a novel potential prognostic biomarker in patients with nasopharyngeal carcinoma. Hereditas 159:1.
Crossref
Pooja Yadav, Shreetama Bandyopadhayaya, Bridget M. Ford & Chandi Mandal. (2021) Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis. Current Drug Targets 22:10, pages 1129-1148.
Crossref
Mohammad Reza Karimzadeh, Peyman Pourdavoud, Naeim Ehtesham, Mohaddese Qadbeigi, Masood Movahedi Asl, Behrang Alani, Meysam Mosallaei & Bahram Pakzad. (2020) Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy. Cancer Gene Therapy 28:3-4, pages 157-174.
Crossref
Peihua Liu, Longxiang Wu, Harripersaud Chand, Chao Li, Xiheng Hu & Yangle Li. (2020) Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer. Life Sciences 261, pages 118311.
Crossref
Yuanbo Kang, Weihan He, Caiping Ren, Jincheng Qiao, Qiuyong Guo, Jingyu Hu, Hongjuan Xu, Xingjun Jiang & Lei Wang. (2020) Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma. Signal Transduction and Targeted Therapy 5:1.
Crossref
Supriya K. Singh, Raman Bahal & Theodore P. Rasmussen. (2020) Evidence that miR-152-3p is a positive regulator of SETDB1-mediated H3K9 histone methylation and serves as a toggle between histone and DNA methylation. Experimental Cell Research 395:2, pages 112216.
Crossref
Rady E. El-Araby, Mahmoud A. Khalifa, Mona M. Zoheiry, Manal Y. Zahran, Mohamed I. Rady, Raafat A. Ibrahim, Mohamed D. El-Talkawy & Faiza M. Essawy. (2019) RETRACTED ARTICLE: The interaction between microRNA-152 and DNA methyltransferase-1 as an epigenetic prognostic biomarker in HCV-induced liver cirrhosis and HCC patients. Cancer Gene Therapy 27:6, pages 486-497.
Crossref
Liuting Hu, Heyu Zhang, Bingyang Wang, Qiang Ao & Zhiyi He. (2020) MicroRNA-152 attenuates neuroinflammation in intracerebral hemorrhage by inhibiting thioredoxin interacting protein (TXNIP)-mediated NLRP3 inflammasome activation. International Immunopharmacology 80, pages 106141.
Crossref
Zhenxiang Rong, Yi Rong, Yingru Li, Lei Zhang, Jingwen Peng, Baojia Zou, Nan Zhou & Zihao Pan. (2020) Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients. Frontiers in Oncology 10.
Crossref
Xinyun Fang & Renchun Yan. (2019) RETRACTED: miR-152 inhibits the proliferation and invasion of chordoma cells by targeting HOXC8 . Journal of International Medical Research 47:10, pages 5185-5193.
Crossref
Jing Guo, Mengmeng Chen, Guihai Ai, Weipu Mao, Huan Li & Jianhong Zhou. (2019) Hsa_circ_0023404 enhances cervical cancer metastasis and chemoresistance through VEGFA and autophagy signaling by sponging miR-5047. Biomedicine & Pharmacotherapy 115, pages 108957.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.